| LPCN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LPCN shares outstanding history going back to 7/25/2013:
Also see: LPCN Market Cap History LPCN YTD Return |
LPCN Shares Outstanding History — Lipocine Share Count Over Time
As of 5/6/2026 Lipocine has 8.24 million LPCN shares outstanding. Investors often track the LPCN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows LPCN share count trends over time, with 50 historical shares outstanding datapoints presented, dating back to 7/25/2013.
| LPCN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LPCN Historical Shares Outstanding: +91.29% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LPCN Stock Price Chart |
| About Lipocine Inc (New) |
| Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for Central Nervous System (CNS) disorders. Its clinical development candidates include: LPCN 1154, oral brexanolone, for treatment of postpartum depression, LPCN 2101 for epilepsy, LPCN 2203 for essential tremor and LPCN 1148, a novel androgen receptor agonist prodrug for oral administration targeted for the management of symptoms associated with liver cirrhosis. We show 50 historical shares outstanding datapoints in our coverage of LPCN's shares outstanding history. Understanding the changing numbers of LPCN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LPCN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LPCN by allowing them to research LPCN shares outstanding history as well as any other stock in our coverage universe. |
| LPCN Current Stock Quote |
Quotes delayed 20 minutes  Free LPCN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| LPCN Share Performance |
| Shares Outstanding Peers |
| Lipocine (LPCN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
LPNT Shares Outstanding History LPTX Shares Outstanding History LQDA Shares Outstanding History LRMR Shares Outstanding History LSTA Shares Outstanding History LTRN Shares Outstanding History LUCD Shares Outstanding History LUMO Shares Outstanding History LUNG Shares Outstanding History LVGO Shares Outstanding History More Healthcare companies » |
LPCN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
